US Patent 11977081 ANGPTL8 assay and uses thereof
Patent 11977081 was granted and assigned to Regeneron Pharmaceuticals on May, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11977081 ANGPTL8 assay and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
